Facebook Instagram Linkedin Soundcloud Twitter Youtube
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Search
FDAReview.org A PROJECT OF THE INDEPENDENT INSTITUTE
  • Home
  • Blog
  • Issues
    • History of the FDA
    • Approval
    • Drug Development
    • Safety
    • Theory of Harm
    • FDA Incentives
    • Where Is the Market Failure Argument?
    • Medical Devices
    • Reform Options
    • Voluntary Provisions
    • Managing Risky Products
  • Publications
  • Features
    • Glossary
    • Links
    • Quotations
    • References
  • About
  • Donate
Home 2019 October

Monthly Archives: October 2019

Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question
Blog

Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question

Raymond March -
October 29, 2019
0
Is Right-to-Try Legislation a Bust? Time for a Second Opinion.
Blog

Is Right-to-Try Legislation a Bust? Time for a Second Opinion.

Raymond March -
October 17, 2019
0
© Newspaper WordPress Theme by TagDiv